We provide you with 20 years of free, institutional-grade data for SONN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SONN. Explore the full financial landscape of SONN stock.
| Reported Date | CIK | Ticker | Type |
|---|
Sonnet BioTherapeutics Holdings, Inc(NASDAQ:SONN) 
Sonnet BioTherapeutics Holdings, Inc., an oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding (FHAB) technology, which utilizes human single chain antibodies fragment that binds to and hitch...
Website: http://www.sonnetbio.com
Founded: 1999
Full Time Employees: 30
CEO: Pankaj Mohan
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about SONN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.